Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
25. June 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16531
Articles 1 - 20 / 330603
Real-World Outcomes and Clinicopathologic Features of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer in a Mexican Cohort.
JCO Glob Oncol
Grajales-Alvarez R, Rubio-Anguiano BL, Valencia-Cedillo R, Talamantes-Gómez E, Pichardo-Piña C, Dip-Borunda K.
PMID: 42341245 [PubMed - in process]
Discussion: Impact of Breast Cancer Surgery on Physical Well-Being of the Chest: A Longitudinal BREAST-Q Study.
Plast Reconstr Surg
Shammas RL, Matros E.
PMID: 42340824 [PubMed - in process]
Impact of Breast Cancer Surgery on Physical Well-Being of the Chest: A Longitudinal BREAST-Q Study.
Plast Reconstr Surg
Marco E, Liaqat A, Shamoun F, Hosseini B, Metcalfe KA, Lim DW, O'Neill AC, Hofer SOP, Croke J, Zhong T.
PMID: 42340823 [PubMed - indexed for MEDLINE]
Combining Conventional MRI and DCE-MRI Radiomics for Prediction of Breast Cancer Molecular Subtypes: A Retrospective Single-Center Cross-Sectional Study.
Clin Ter
Hue TT, Huong NT, Hung ND.
PMID: 42340785 [PubMed - indexed for MEDLINE]
A Nomogram for Preoperative Prediction of Ovarian Cancer Risk: A Single-Center Study from Vietnam.
Clin Ter
Tuan NQ, Nam NP, Phuong NH, Tot DV, Chien CQ, Tu NP.
PMID: 42340783 [PubMed - indexed for MEDLINE]
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
Breast Cancer
Yamanaka T, Sohn J, Sudo K, Mukai H, Yamamoto N, Chung CF, Lu YS, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Noguchi E, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K.
PMID: 42340618 [PubMed - as supplied by publisher]
Breast cancer screening in Europe and the role of general practitioners: A 32-country comparative survey.
Eur J Gen Pract
Papageorgiou DI, Smyrnakis E, Harris M, Skuja I, Ad, Apostolova G, Bensemmane S, Brekke M, Buczkowski K, Buono N, Burgers J, Danilenko J, Högberg C, Kafadar D, Koskela T, Kral N, Kraxner R, Küppers L, Legoff D, Marzo-Castillejo M, Pless A, Ponzel N, Puia A, Radzevi, Redmond P, Särgava K, , Sulashvili M, Vedsted P, Wöstmann X, Zafirovska M, Zaidan R, Hoffman R.
PMID: 42340409 [PubMed - in process]
Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics.
Genet Epidemiol
Shi Y, Xu W, Hu P.
PMID: 42339999 [PubMed - in process]
LODDS-based nomogram for breast cancer-specific survival in surgically treated young breast cancer.
Biomol Biomed
Wang Z, Yang Z, Zhang H.
PMID: 42339890 [PubMed - as supplied by publisher]
Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study.
Front Oncol
Lu J, Song X, Zhang C, Zhu Y, Yang H, Li Y.
PMID: 42339129 [PubMed]
Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology.
Cancer Biother Radiopharm
Xing X, Yu H, Zhang S.
PMID: 42338131 [PubMed - as supplied by publisher]
Response to the Letter to the Editor-Comment on 'The Effect of Theory-Guided Positive Psychological Interventions for Patients With Breast Cancer: A Systematic Review and Meta-Analysis'.
J Clin Nurs
Chair SY, Fan MSN, Gao R.
PMID: 42337949 [PubMed - as supplied by publisher]
Over-presentation of apolipoprotein E gene variants E3/E4 and cardiovascular disease risk factors among Ghanaian breast cancer patients.
BMC Cancer
Antonio DNM, Annani-Akollor M, Fondjo LA, Anang-Quartey Y, Owusu H, Arko-Boham B, Santa S, Quaye O, Tagoe EA.
PMID: 42337705 [PubMed - as supplied by publisher]
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude versus low-altitude regions: a multi-center retrospective study.
Cancer Biol Ther
Tan Y, Ye Y, Zhao W, Jiang H, Wang J, Zhao J, Ma F.
PMID: 42337391 [PubMed - indexed for MEDLINE]
Spatial analyses implicate high stromal tumour-infiltrating CD8(+) lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancer.
Nat Commun
Kinsella Z, Jahangir CA, Nyarko HN, Kalinska-Lysiak D, Gonzalez CA, Murphy V, O'Grady T, Fay J, Sheehan K, Rahman A, Crown JP, Kelly CM, McDade SS, Woods I, Connolly NMC, Prehn JHM, Gallagher WM, O'Connor DP.
PMID: 42337235 [PubMed - in process]
Transcranial direct current stimulation for perioperative depression in breast cancer surgery: a randomized controlled trial.
Transl Psychiatry
Zan W, Zhou M, Qi Y, Wang R, Chen J, Zu C, Li X, Zhou T, Wang L.
PMID: 42336829 [PubMed - as supplied by publisher]
Optimising exercise prescription for cancer-related fatigue, lean mass, physical function and muscle strength in women with breast cancer: a systematic review with dose-response network meta-analysis.
Br J Sports Med
Lopez P, Petropoulou M, Radaelli R, Silveira CB, Molinari T, Torres Muller C, Casara P, Bettariga F, Singh F, Buffart LM, Rech A.
PMID: 42336622 [PubMed - as supplied by publisher]
AI-Assisted HER2 Scoring in Breast Cancer: Diagnostic Agreement and Understanding Discordance.
Lab Invest
Deman F, Rasic D, Broeckx G, Siozopoulou V, Lænkholm AV, Salgado R, Torres-Saavedra PA, Ács B, Dendooven A.
PMID: 42336244 [PubMed - as supplied by publisher]
Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicity.
Am J Hum Genet
Schnaiter S, Santer FR, Csanaky KA, Jensen LA, Zeimet AG, Michailidou K, Spurdle AB, Thomassen M.
PMID: 42335889 [PubMed - as supplied by publisher]
National United Kingdom study of the management of breast cancer locoregional recurrence (MARECA) study: Analysis of disease presentation and patient management.
Eur J Surg Oncol
Morgan JL, Hubbard T, Herbert E, Hartup S, Cheng V, Barry PA, Copson E, Cutress RI, Dave R, Elsberger B, Fairbrother P, Hogan B, Horgan K, Hughes TA, Kirwan CC, Mannu G, McIntosh SA, O'Connell RL, Patani N, Potter S, Rattay T, Sheehan L, Wyld L, Kim B, MARECA study research collaborative.
PMID: 42335799 [PubMed - as supplied by publisher]
Articles 1 - 20 / 330603
Page 1 of 16531
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy